$ADRX 4 SEC Filings

Filed On	Filing
30 Sep 2026	Form 4: Chimovits Erez, Director Received 9,230,509 shares by conversion · Bought 61,516 shares ($1.05M)
30 Sep 2026	Form 4: Gordon Carl L, Director Received 23,255,789 shares by conversion · Bought 950,000 shares ($16.2M)
30 Sep 2026	Form 4: Orbimed Advisors Llc, Director and 4 others Received 23,255,789 shares by conversion · Bought 950,000 shares ($16.2M)
29 Sep 2026	Form 4: Lav Biosciences Fund V, L.p., 10% owner and 2 others Received 11,858,655 shares by conversion
29 Sep 2026	Form 4: Sr One Capital MANAGEMENT, Llc, 10% owner Received 8,336,661 shares by conversion · Bought 1,600,000 shares ($27.2M)
29 Sep 2026	Form 4: George Simeon, Director Received 8,336,661 shares by conversion · Bought 1,600,000 shares ($27.2M)
28 Sep 2026	Form 4: MacLeod Alan Robert, Chief Scientific Officer Granted 170,692 Employee Stock Option (right to buy)
28 Sep 2026	Form 4: Zhu Rui (NMN), Chief Technology Officer Granted 512,076 Employee Stock Option (right to buy)
28 Sep 2026	Form 4: Ackles Robert William, Chief People Officer Granted 85,346 Employee Stock Option (right to buy)
28 Sep 2026	Form 4: Fisk Ryan, CFO and CBO Granted 170,692 Employee Stock Option (right to buy)
28 Sep 2026	Form 4: Li Zhen, Director Granted 1,024,152 Employee Stock Option (right to buy)

Comments